Uploads Contact
/
Login Upload

  • Search Results for 'Biosimilar Patients'

Biological Products: concepts, naming,
Biological Products: concepts, naming,
faustina-dinatale
Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives
Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives
alida-meadow
Understanding Biologics Biologics and Biosimilars
Understanding Biologics Biologics and Biosimilars
calandra-battersby
Application of Biosimilars in RA IN Clinical Practice:
Application of Biosimilars in RA IN Clinical Practice:
conchita-marotz
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
calandra-battersby
Biosimilar biological productEvaluation by the FDA
Biosimilar biological productEvaluation by the FDA
alida-meadow
FDA Approves First Biosimilar Sandozs Zarxio By Jennif
FDA Approves First Biosimilar Sandozs Zarxio By Jennif
pamella-moone
Conference Series LLC
Conference Series LLC
alida-meadow
Recruitment of cancer patients by LCRN
Recruitment of cancer patients by LCRN
karlyn-bohler
Biosimilars 2012 AIPLA Webinar
Biosimilars 2012 AIPLA Webinar
stefany-barnette
A QUM partnership approach to regulating
A QUM partnership approach to regulating
liane-varnes
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less
debby-jeon
High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar
High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar
test
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3
kittie-lecroy
Biosimilars & EU regulation
Biosimilars & EU regulation
karlyn-bohler
Biosimilars in emerging markets- regulatory and Commercial considerations
Biosimilars in emerging markets- regulatory and Commercial considerations
jane-oiler
PSHP President’s Update
PSHP President’s Update
olivia-moreira
PSHP President’s Update
PSHP President’s Update
myesha-ticknor
National Pharmacy Practice
National Pharmacy Practice
debby-jeon
Can we safely discharge TIA patients?
Can we safely discharge TIA patients?
min-jolicoeur
Which Myelofibrosis Patients are Candidates for Upfront Ste
Which Myelofibrosis Patients are Candidates for Upfront Ste
yoshiko-marsland
Update on transplant-ineligible patients:
Update on transplant-ineligible patients:
trish-goza
Maintaining patients on anticoagulants: how to do it
Maintaining patients on anticoagulants: how to do it
olivia-moreira
Partnership for Patients
Partnership for Patients
pamella-moone